Drug Profile
Research programme: atypical antipsychotics - Sigma Tau
Alternative Names: ST 2329Latest Information Update: 08 Aug 2007
Price :
$50
*
At a glance
- Originator sigma-tau SpA
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 06 Sep 2004 Preclinical trials in Schizophrenia in Italy (unspecified route)